Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antoniou

Showing results (111-120 of 395) with videos related to

Pageof 40
Sort By:
The British Journal of Dermatology|January 31, 2012
Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cellsM Vasiadi, A Therianou, K D Alysandratos, et al.
British Journal of Cancer|January 6, 2026
The breast cancer risk assessment pathway in England: a systems analysis of current challenges and ways to improveMaria Valasaki, Lily C Taylor, Victoria G Woof, et al.
BJGP Open|April 15, 2025
Primary care online training on multifactorial breast cancer risk: pre-post evaluation studyFrancisca Stutzin Donoso, Juliet A Usher-Smith, Lorenzo Ficorella, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 9, 2005
Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferationA J Stratigos, N Kapranos, E Petrakou, et al.
The British Journal of Dermatology|January 17, 2007
p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variantsI Stefanaki, A J Stratigos, G Dimisianos, et al.
QJM : Monthly Journal of the Association of Physicians|October 2, 2013
High intensity, interval exercise improves quality of life of patients with chronic heart failure: a randomized controlled trialC Chrysohoou, G Tsitsinakis, I Vogiatzis, et al.
Journal of Medical Genetics|May 31, 2015
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsSarah Jervis, Honglin Song, Andrew Lee, et al.
Breast Cancer Research and Treatment|November 19, 2009
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Paul Fahey, Xiaoqing Chen, et al.
American Journal of Human Genetics|January 3, 2001
After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancerJ Cui, A C Antoniou, G S Dite, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 9, 2024
Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling studyCatherine Huntley, Bethany Torr, Grace Kavanaugh, et al.
Pageof 40

Showing results (111-120 of 395) with videos related to

Sort By:
Pageof 40
The British Journal of Dermatology|January 31, 2012
Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cellsM Vasiadi, A Therianou, K D Alysandratos, et al.
British Journal of Cancer|January 6, 2026
The breast cancer risk assessment pathway in England: a systems analysis of current challenges and ways to improveMaria Valasaki, Lily C Taylor, Victoria G Woof, et al.
BJGP Open|April 15, 2025
Primary care online training on multifactorial breast cancer risk: pre-post evaluation studyFrancisca Stutzin Donoso, Juliet A Usher-Smith, Lorenzo Ficorella, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 9, 2005
Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferationA J Stratigos, N Kapranos, E Petrakou, et al.
The British Journal of Dermatology|January 17, 2007
p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variantsI Stefanaki, A J Stratigos, G Dimisianos, et al.
QJM : Monthly Journal of the Association of Physicians|October 2, 2013
High intensity, interval exercise improves quality of life of patients with chronic heart failure: a randomized controlled trialC Chrysohoou, G Tsitsinakis, I Vogiatzis, et al.
Journal of Medical Genetics|May 31, 2015
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsSarah Jervis, Honglin Song, Andrew Lee, et al.
Breast Cancer Research and Treatment|November 19, 2009
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Paul Fahey, Xiaoqing Chen, et al.
American Journal of Human Genetics|January 3, 2001
After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancerJ Cui, A C Antoniou, G S Dite, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 9, 2024
Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling studyCatherine Huntley, Bethany Torr, Grace Kavanaugh, et al.
Pageof 40